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ABSTRACT 
 
 Organisms with identical genome sequences can show substantial 
differences in their phenotypes owing to epigenetic changes that result in different 
use of their genes. Epigenetic regulation of gene expression plays a key role in the 
control of several fundamental processes in the biology of malaria parasites, 
including antigenic variation and sexual differentiation, among others. Some of the 
histone modifications and chromatin modifying enzymes that control the epigenetic 
states of malaria genes have been characterized, and their functions are beginning 
to be unraveled. The fundamental principles of epigenetic regulation of gene 
expression appear to be conserved between malaria parasites and model 
eukaryotes, but important peculiarities exist. Here we review the current knowledge 
of malaria epigenetics and discuss how it can be exploited for the development of 
new molecular markers and new types of drugs that may contribute to malaria 
eradication efforts.  
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INTRODUCTION 
 
Epigenetic regulation of gene expression refers to heritable changes in 
transcription that occur in the absence of alterations in the primary sequence of 
DNA. Numerous important biological pathways in eukaryotes involve epigenetic 
regulation, both in health and during disease. Chromatin is the main platform 
where epigenetic processes take place, such that epigenetic traits are typically 
mediated by DNA modifications (such as methylation) or by changes in chromatin 
structure such as histone post-translational modifications or use of histone 
variants. In fact, there is an accepted “relaxed” use of the term epigenetics that 
includes all chromatin-based processes that affect transcription, regardless of 
whether or not information is transmitted through cell division.  
 In malaria parasites, epigenetic regulation of gene expression has been 
extensively studied only in Plasmodium falciparum. For many years, studying 
epigenetics in this parasite was almost synonymous to studying the regulation of 
var genes, which are important for antigenic variation and virulence (Kyes et al. 
2001). However, recent findings have revealed a more general role for epigenetics 
in malaria parasite biology, including processes as diverse as erythrocyte invasion, 
solute transport, or formation of sexual forms necessary for human-to-mosquito 
transmission. The contribution of epigenetic regulation of gene expression to these 
processes stems from the clonally variant expression of some of the genes 
involved. Silencing of clonally variant genes, which is a process truly controlled at 
the epigenetic level (Cortés et al. 2012), generally depends on histone 
modifications that result in reversible formation of repressive chromatin structures 
(heterochromatin), but several additional layers of regulation operate specifically on 
particular gene families such as var genes. 
 Genome-wide studies of heterochromatin marks or transcriptional variation 
identified many genes regulated at the epigenetic level that are not involved in the 
processes mentioned above, indicating that epigenetic regulation of gene 
expression plays a role in the control of other as yet uncharacterized biological 
processes (Lopez-Rubio et al. 2009; Flueck et al. 2009; Rovira-Graells et al. 2012). 
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Years to come will reveal the biological significance of epigenetic regulation of 
these genes. In all cases, epigenetic changes are likely to imply translating the 
same genome into alternative transcriptomes and phenotypes, increasing the 
plasticity of parasite populations and favoring their survival.  
  
 
PROCESSES REGULATED AT THE EPIGENETIC LEVEL IN MALARIA 
PARASITES 
 
 Numerous P. falciparum genes involved in host-parasite interactions show 
clonally variant expression, such that they are expressed in some individual 
parasites but not in others that are genetically identical (Table 1). The active or 
silenced states of these genes are clonally transmitted during asexual replication, 
with switches between the two states occurring at low frequencies. The predicted 
functions for clonally variant genes suggest that transcriptional variation results in 
both antigenic and functional differences at several stages along the parasite’s life 
cycle (Fig. 1), but the phenotypic alterations associated with changes in the 
expression of specific clonally variant genes have been elucidated in only a few 
cases. In this section we describe the known processes in which epigenetic 
changes determine alternative phenotypes. A common theme is that for processes 
in which the parasite requires alternative operational states to adapt to changes in 
its environment or to evade host immune responses, alternative epigenetic states 
exist for some of the genes linked to the process.  
 
Antigenic variation and cytoadherence 
 Observations of both human and animal infections clearly demonstrate that 
malaria parasites are capable of maintaining persistent, chronic infections for 
extended periods of time, even in the presence of a robust antibody response of 
the infected host. In experimental human infections, parasites have been observed 
to persist for over a year, frequently displaying characteristic waves of parasites 
reminiscent of similar population dynamics displayed by other infectious organisms 
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including African trypanosomes (Miller et al. 1994). Thus it is clear that malaria 
parasites are capable of systematic antigenic variation that results in immune 
evasion, presumably through alterations made to proteins displayed on the surface 
of infected erythrocytes. In the case of P. falciparum, the formation of knobs on the 
infected erythrocyte membrane as well as the induction of cytoadherent properties 
of infected cells provided additional evidence for the placement of antigenically 
variant molecules on the infected cell surface (Miller et al. 2002). The variant 
surface properties of the infected erythrocytes was linked to epigenetic regulation 
of gene expression with the discovery and description in P. falciparum of the var 
multi-copy gene family and the multitude of alternative forms of the P. falciparum 
erythrocyte membrane protein 1 (PfEMP1) that it encodes (Smith et al. 1995; 
Baruch et al. 1995; Su et al. 1995).  
 Individual parasites typically express only one var gene at a time, a pattern 
known as mutually exclusive expression that operates on top of clonal variation 
and results in a single form of PfEMP1 on the erythrocyte surface. All variants of 
PfEMP1 include a single transmembrane domain that passes through the 
erythrocyte membrane, thus anchoring a long, hyper-variable portion of the protein 
that binds to endothelial surface receptors and thereby mediates cytoadhesion. 
Cytoadhesion of infected erythrocytes effectively removes them from the peripheral 
circulation, a phenomenon referred to as sequestration, thereby enabling them to 
avoid passage through the spleen where they would be detected and destroyed. 
The different forms of PfEMP1 display different binding specificities, utilizing 
alternative host endothelial surface ligands for adhesion. This results in parasitized 
erythrocytes sequestering within different host tissues depending on which var 
gene (and the encoded form of PfEMP1) is expressed (Montgomery et al. 2007). 
Sequestration within the brain or the placenta have been directly linked to cerebral 
malaria and pregnancy-associated malaria respectively, thus making PfEMP1 the 
best characterized virulence factor of malaria caused by P. falciparum. PfEMP1 
also mediates rosetting, the binding of infected to non-infected erythrocytes that is 
also associated with virulence (Miller et al. 2002).    
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 With the availability of complete genome sequences for several Plasmodium 
species infecting both primates and rodents, it has become possible to catalogue 
the many multi-copy gene families found within these genomes. Gene families 
encoding variant surface proteins have been discovered in multiple Plasmodium 
species, suggesting that this is a universal characteristic of malaria parasites. 
While some of these gene families are conserved throughout the Plasmodium 
lineage, others appear to be species specific. In addition to the var gene family, 
which includes approximately 60 members per haploid genome, P. falciparum also 
possesses several other large, multi-copy gene families likely involved in antigenic 
variation. These include the rif/stevor/Pfmc-2tm (~200 copies) and the surfins (~10 
copies) (Weber 1988; Kyes et al. 1999; Sam-Yellowe et al. 2004; Winter et al. 
2005). The largest multi-copy gene family in P. vivax is referred to as vir (~350 
copies) (del Portillo et al. 2001), which appears to have orthologous gene families 
in the primate parasite P. knowlesi (kir) and in the rodent parasites P. berghei (bir), 
P. yoelii (yir) and P. chabaudi (cir) (Fischer et al. 2003; Janssen et al. 2004) and is 
also likely a distant orthologue of the rif genes of P. falciparum (Janssen et al. 
2004). P. knowlesi also possesses the sica-var family (~100 copies) which 
encodes a protein linked to cytoadherence similar to PfEMP1 (al-Khedery et al. 
1999). In all cases, expression is limited to one or a limited subset of the members 
of each gene family at any given time. Activation and silencing of the genes of 
these families, as well as switching expression between members, are all thought 
to be regulated epigenetically.      
 
Erythrocyte invasion 
 Invasion of erythrocytes is an essential step of the asexual cycle of malaria 
parasites. After schizonts burst, merozoites are released into the blood stream and 
quickly invade new erythrocytes to start a new cycle of replication. Erythrocyte 
invasion involves several differentiated steps, starting with initial contact, followed 
by merozoite reorientation and apical attachment that lead to the formation of a 
moving junction that progresses until the merozoite is internalized (Wright and 
Rayner 2014; Weiss et al. 2015). The small eba and Pfrh gene families, each 
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including 4-5 members, encode adhesins that are released from apical organelles 
and interact with erythrocyte receptors to mediate merozoite reorientation / apical 
attachment. Of note, merozoites can use alternative pathways for this step of 
invasion, each involving a different set of erythrocyte receptors. With the exception 
of Pfrh5, the genes of the eba and Pfrh families are non-essential and appear to be 
functionally redundant (Reed et al. 2000; Maier et al. 2003; Duraisingh et al. 2003; 
Stubbs et al. 2005; Wright and Rayner 2014). As expected from the existence of 
alternative invasion pathways and the non-essentiality of these genes, several eba 
and Pfrh genes are spontaneously silenced in some parasite lines, and clonally 
variant expression mediated by epigenetic mechanisms has been directly 
demonstrated in some cases (Taylor et al. 2002; Duraisingh et al. 2003; Cortés et 
al. 2007; Jiang et al. 2010; Crowley et al. 2011). Importantly, variant expression of 
invasion adhesins has also been observed in field isolates (Cortés 2008; Gomez-
Escobar et al. 2010). While the relation between eba and Pfrh expression patterns 
and the use of specific invasion pathways is complex and not completely 
understood, it is generally accepted that changes in the expression of these genes 
lead to phenotypic variation in the process of invasion (Duraisingh et al. 2003; 
Cortés 2008; Wright and Rayner 2014).  
 Understanding what selective advantage the clonally variant expression of 
invasion adhesins confers to parasites is an unresolved question. Although 
flexibility in front of genetic variability in host erythrocytes is an appealing 
possibility, mutations in the majority of erythrocyte receptors that P. falciparum 
uses for invasion are rare, especially in Africa. Immune evasion provides an 
alternative explanation for the potential advantage that variant expression of 
invasion ligands may confer to the parasites: while the number of genes in the eba 
or Pfrh families is small for “classic” antigenic variation, variant expression may act 
synergistically with genetic polymorphism among different isolates to evade 
acquired immune responses (Cortés 2008; Wright and Rayner 2014). 
 The proteins encoded by some members of the variantly expressed large 
multigene families rif, stevor and surfin discussed above also appear to be 
expressed in merozoites (Chan et al. 2014), although their function in the 
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merozoite remains unknown and may be unrelated to invasion. Another gene 
encoding a protein expressed in merozoites that shows clonally variant expression 
is mspdbl2, a member of the small msp3-like family. MSPDBL2 is located at the 
merozoite surface, where it may play a role in initial steps of erythrocyte invasion. 
This intriguing gene, which carries the epigenetic marks of silencing associated 
with clonally variant gene expression (Lopez-Rubio et al. 2009; Flueck et al. 2009), 
appears to be silenced in the vast majority of parasites and activated in only small 
subpopulations (~1% of parasites in most lines) (Amambua-Ngwa et al. 2012). 
However, the phenotypic differences resulting from the alternative transcriptional 
states of mspdbl2 remain unknown. 
 
Infected erythrocyte permeability 
 The transport of many solutes across the infected erythrocyte membranes is 
mediated by the plasmodial surface anion channel (PSAC), a broad selectivity 
channel with several unusual transport properties (Desai 2014). Recent research 
has established that the product of the parasite genes clag3.1 or clag3.2 is 
required for the formation of functional PSAC and efficient nutrient acquisition 
(Nguitragool et al. 2011; Pillai et al. 2012). This was an unexpected finding 
because these genes were previously thought to participate in either 
cytoadherence or erythrocyte invasion (Gupta et al. 2015).  
 The link between solute uptake and epigenetics comes from studies 
demonstrating that clag3 genes show clonally variant expression regulated at the 
epigenetic level (Cortés et al. 2007; Comeaux et al. 2011; Crowley et al. 2011). 
Interestingly, clag3 genes generally show mutually exclusive expression, such that 
individual parasites express either clag3.1 or clag3.2 (Cortés et al. 2007). 
However, it appears to not be strict, with occasional parasites escaping mutual 
exclusion (Rovira-Graells et al. 2015). While the driving force for the epigenetic 
regulation of the expression of clag3 genes remains unclear, it is reasonable to 
hypothesize that expression of alternative clag3 genes may result in different 
solute transport phenotypes, which may play a role in the adaptation of the parasite 
to varying concentrations of nutrients and other solutes in the host plasma. This 
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might explain why mutually exclusive expression need not be strict, since silencing 
or expressing both genes simultaneously could provide additional phenotypic 
plasticity to parasite populations. In support of this view, challenging P. falciparum 
cultures with the toxic compound blasticidin S, which requires the PSAC for 
transport across the infected erythrocyte membrane, results in selection of 
parasites with dramatic switches in clag3 expression (Sharma et al. 2013; Mira-
Martínez et al. 2013). This is indicative of a role for clag3 epigenetic regulation in 
the tradeoff between excluding toxic compounds from infected erythrocytes and 
allowing the entrance of nutrients necessary for normal growth. These results also 
show that switches in clag3 expression constitute a novel anti-malarial drug 
resistance mechanism controlled at the epigenetic level. Last, CLAG3 proteins are 
exposed on the erythrocyte surface (Nguitragool et al. 2011), so in addition to 
influencing solute transport, switches in the expression of clag3 genes may also 
play a role in antigenic variation and immune evasion. 
 
Sexual conversion 
 The complex life cycle of malaria parasites includes multiple well-
differentiated stages through which the parasite progresses in an ordered manner. 
The single developmental decision for the parasite occurs during asexual growth in 
the blood stream: at each cycle of replication the parasite makes a choice between 
continuing asexual multiplication, as the majority of parasites do, or irreversibly 
converting into male or female gametocytes, which are the sexual forms of the 
parasite necessary for transmission to another host via a mosquito vector (Fig. 1).  
 Genome-wide studies on transcriptional variation and epigenomic studies 
identified a member of the ApiAP2 family of transcriptional regulators that shows 
clonally variant expression (Rovira-Graells et al. 2012) and carries epigenetic 
marks of silencing (Lopez-Rubio et al. 2009; Flueck et al. 2009). The 
characterization of this transcriptional regulator, termed PfAP2-G, revealed that it 
plays an essential role in triggering sexual differentiation, such that the gene is by 
default silenced by heterochromatin-based epigenetic mechanisms, and only the 
few parasites in which the gene is stochastically activated convert into 
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gametocytes (Kafsack et al. 2014). These results raised the idea that sexual 
conversion is regulated at the epigenetic level, a view that was later corroborated 
by studies in which specific epigenetic factors were depleted (Brancucci et al. 
2014; Coleman et al. 2014). The ortholog of pfap2-g in the distantly related murine 
malaria parasite P. berghei, pbap2-g, also plays a key role in gametocyte formation 
(Sinha et al. 2014). This observation suggests that ap2-g is a conserved regulator 
of sexual conversion in malaria parasites; whether or not epigenetic control of the 
process is a conserved feature in all Plasmodium species awaits experimental 
confirmation.  
 The proportion of parasites that convert into sexual forms varies among 
isogenic parasite subclones (Kafsack et al. 2014). Spontaneous sexual conversion 
rates in these subclones are stable, indicating that as yet uncharacterized 
epigenetic mechanisms transmit the probability of pfap2-g activation and 
subsequent sexual conversion. Additionally, sexual conversion rates are affected 
by some environmental conditions (Bousema and Drakeley 2011), which opens up 
exciting perspectives about the possibility that environmental cues influence pfap2-
g epigenetic states. This would provide one of the first examples in malaria of the 
parasite sensing the state of its host and producing a directed transcriptional 
response.  
 
Epigenetic variation and adaptation to environmental changes: bet-hedging 
 Clonally variant expression is an intrinsic property of many P. falciparum 
gene families involved in disparate cellular processes (Rovira-Graells et al. 2012). 
This implies that isogenic parasite populations spontaneously become 
transcriptionally heterogeneous during normal growth, such that different individual 
parasites have different combinations of active and epigenetically-silenced genes. 
This diversity confers plasticity to parasite populations, because it provides the 
grounds for dynamic natural selection of parasites with highest fitness as changes 
in the environment occur. Adaptive strategies based on the stochastic generation 
of phenotypic diversity within populations before any challenge occurs, as opposed 
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to directed adaptive responses, are commonly referred to as bet-hedging (Veening 
et al. 2008; Simons 2011).  
 The high level of spontaneous transcriptional diversity observed within 
isogenic parasite populations and the apparently stochastic nature of expression 
switches in clonally variant genes support the view that malaria parasites 
commonly use bet-hedging adaptive strategies (Rovira-Graells et al. 2012). This 
idea is also supported by the proposed limited ability of P. falciparum to adapt via 
directed transcriptional responses (Le Roch et al. 2008; Ganesan et al. 2008), 
although this remains controversial (Deitsch et al. 2007). In addition to the 
processes described above in which epigenetic changes can be ascribed to 
alterations in specific phenotypes, the predicted functions of some of the clonally 
variant genes identified (Table 1) make it tempting to speculate that they modulate 
fitness in front of the majority of conditions that commonly fluctuate in the human 
blood, which is the environment where P. falciparum asexual stages reside. 
However, altogether there are few examples of well-defined adaptive pathways to 
specific challenges via bet-hedging in malaria, so it is still unclear whether 
epigenetic variation and bet-hedging play a general role in the adaptation of 
malaria parasite populations to changes in their environment. More experimental 
insight into the association between epigenetic diversity and long-term fitness in 
natural environments, and the identification of the clonally variant genes that 
mediate adaptation to specific changes in the parasite environment, are clearly 
needed to determine the actual contribution of bet-hedging to malarial adaptation.  
 
EPIGENETIC MECHANISMS IN PLASMODIUM FALCIPARUM 
 
 Given the important role that epigenetic regulation of gene expression plays 
in the biology of malaria parasites, considerable work has focused on determining 
the molecular mechanisms that underlie these processes. The lion’s share of this 
work has been performed with P. falciparum, although additional work has also 
been done in the rodent models of malaria. In this section we summarize recent 
12 
 
studies that shed light on the molecular basis for epigenetic regulation in P. 
falciparum. 
 
Chromatin structure across the life cycle 
 As mentioned briefly above, epigenetic regulation of gene expression 
involves heritable modifications to the way the genome is packaged that influence 
gene activation and silencing. Many of these modifications occur on histones, the 
protein subunits that comprise the nucleosomes around which the DNA strands of 
the chromosomes are wrapped. Modifications that increase the affinity of the 
histones to the DNA, thereby resulting in a more condensed chromatin structure 
that is less accessible to transcription complexes (called heterochromatin), lead to 
silencing of gene expression, while those that result in more open chromatin 
(called euchromatin) are associated with active regions of the genome. Typical 
nucleosome modifications include the incorporation of variant histones or post-
translational modifications (most often acetylation or methylation) to the N-terminal 
“tails” of histones H3 and H4. Many of the enzymes that catalyze the addition or 
removal of these modifications have been identified encoded in the P. falciparum 
genome and some have been experimentally characterized (Table 2). Once 
formed, heterochromatin and euchromatin are separated within the nucleus, with 
heterochromatin generally found segregated to the nuclear periphery. In P. 
falciparum, as in other eukaryotes, many regions of the genome are found in either 
a euchromatic or a constitutively heterochromatic state that is the same in all cells, 
indicating that the chromatin state in such regions is likely dictated by the 
underlying primary DNA sequence. Although constitutive heterochromatin is in 
general transcriptionally silent, some long non-coding RNAs (lncRNAs) are 
expressed from subtelomeric repeats heterochromatin (Sierra-Miranda et al. 2012; 
Broadbent et al. 2015). However, other regions of the genome can be found in 
alternative chromatin states in different individual cells (Fig. 2). In such regions, 
known as facultative heterochromatin or bistable chromatin, once one or the other 
state is established the resulting gene expression patterns are heritable through 
multiple cell generations, a phenomenon frequently referred to as epigenetic 
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memory. However these states are reversible, thus a gene that is silenced for 
many generations can once again revert to the active state, and vice versa. Herein 
lies the mechanistic basis for clonally variant expression and the biological 
phenomena described above.  
 Progression through the different stages of the asexual cycle of P. 
falciparum requires a tightly regulated cascade of gene expression in which most 
of the ~5300 genes display a narrowly defined timing of activation (Bozdech et al. 
2003; Le Roch et al. 2003). The general chromatin structure of the genome as a 
whole similarly displays cyclical, dynamic changes. The density of nucleosomes 
along the length of the chromosomes, called nucleosome occupancy, is somewhat 
depleted as cells enter S-phase in the trophozoite stage, then becomes maximal in 
schizonts (Bunnik et al. 2014). Nucleosomes also appear to be clearly positioned 
around transcriptional landmark sites, including transcription start sites, regulatory 
elements and splice donor and acceptor sites (Kensche et al. 2016). Euchromatic 
upstream regulatory regions of most genes are typically associated with presence 
of the histone variants H2A.Z and H2B.Z, acetylation of histone H3 on the lysine in 
the 9th position (H3K9ac) and methylation of the lysine in the 4th position 
(H3K4me3). The presence of both of these histone modifications shows dynamic 
changes over the course of the asexual cycle, such that H3K9ac levels directly 
correlate with temporal patterns of gene expression whereas H3K4me3 increases 
throughout the genome from low levels in rings to highly enriched levels late in the 
cycle (Lopez-Rubio et al. 2009; Salcedo-Amaya et al. 2009; Bartfai et al. 2010; 
Hoeijmakers et al. 2013). Other histone modifications similarly correlate with 
transcript levels, and their incorporation into the chromatin at specific regions of the 
genome appears to depend on the underlying DNA sequence (Gupta et al. 2013). 
All of these dynamic chromatin changes that occur over the course of the asexual 
cycle within constitutively euchromatic regions of the genome are unlikely to carry 
heritable information (Cortés et al. 2012), but together they contribute to the 
cascade of gene activation that enables the parasites to faithfully complete each 
round of schizogony. Special chromatin also forms at centromeres, including the 
incorporation of the variant histone cenH3. The centromeres from the different 
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chromosomes cluster together within the nucleus during mitosis and cytokinesis, 
but dissociate after the merozoites re-invade erythrocytes and reinitiate a new 
cycle (Hoeijmakers et al. 2012). Additionally, DNA methylation has also been 
detected and proposed to contribute to transcriptional regulation (Ponts et al. 
2013).  
 
General mechanisms regulating clonally variant gene expression 
 As mentioned above, genes that display clonally variant expression are 
associated with bistable chromatin, which can be found as either euchromatin or 
facultative heterochromatin, resulting in either activation or silencing, respectively. 
This chromatin state is heritable and thus must be faithfully reproduced as the 
genome transitions through multiple rounds of replication and division during 
schizogony. Only relatively rarely does a gene switch transcriptional states, 
however the ability to switch is key for parasites to be able to display clonally 
variant expression and is indispensable for processes like antigenic variation that 
depend on generating variability over time, and for bet-hedging strategies that 
enable parasite populations to respond to changes in their environment. In addition 
to switching transcriptional states, some genes also belong to gene families in 
which only one or a small number of genes are active at a time (frequently referred 
to as mutually exclusive expression). Thus activation of one gene necessitates the 
simultaneous silencing of the previously active member of the family, therefore 
requiring a mechanism of coordination within the family.  
 Significant progress has been made in recent years in identifying and 
characterizing the epigenetic components associated with activation and silencing 
of individual genes. Much less is understood regarding what controls switching 
between transcriptional states, and the molecular basis for mutually exclusive 
expression within gene families remains entirely mysterious. The clonally variant 
genes involved in antigenic variation (var, rifin, stevor, Pfmc-2tm), alternative 
erythrocyte invasion pathways (eba and Pfrh), infected erythrocyte permeability 
(clag3.1 and clag3.2) and sexual conversion (pfap2-g) all share certain epigenetic 
characteristics. When they are transcriptionally silent, they are bound by 
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nucleosomes that incorporate the silent mark H3K9me3, in particular surrounding 
the transcriptional start site (Chookajorn et al. 2007; Lopez-Rubio et al. 2009; Jiang 
et al. 2010; Crowley et al. 2011; Kafsack et al. 2014). When individual genes are 
activated, H3K9me3 is replaced by H3K9ac, and this appears to be a key step in 
switching the transcriptional state of the gene (Lopez-Rubio et al. 2007; Crowley et 
al. 2011). Once in place, the activating or silencing histone marks are maintained 
throughout the remainder of the asexual cycle, even at points in the cycle when the 
genes are inactive. Further, these marks are faithfully reproduced as the genome 
replicates through schizogony, resulting in epigenetic memory. Changes in these 
histone modifications occur at low frequencies, resulting in clonal variation. The 
H3K9me3 modification is recognized by heterochromatin protein 1 (HP1) which 
begins the chromatin condensation process that results in segregation into the 
nuclear periphery and prevents transcription (Perez-Toledo et al. 2009; Flueck et 
al. 2009). The importance of HP1 in this process is shown by experiments in which 
its expression is disrupted. In the absence of HP1, all clonally variant genes 
become transcriptionally active simultaneously, leading to disruption of antigenic 
variation and rapid differentiation into the sexual conversion pathway (Brancucci et 
al. 2014). A similar phenotype results from disruption of the histone deacetylase 
PfHda2 (Coleman et al. 2014), further demonstrating the shared epigenetic 
mechanisms controlling expression of clonally variant gene families. These 
profound phenotypes reveal the importance of proper regulation of 
heterochromatin for parasite biology. 
  
Specific mechanisms regulating var gene expression 
 Of the genes that undergo clonally variant expression, the most work has 
focused on the var gene family that encodes the variant surface protein PfEMP1. 
The haploid genome of any given parasite includes ~60 var genes, which are 
expressed in a mutually exclusive manner. As described above, the active gene is 
associated with chromatin that incorporates the H3K9ac modification, while the 
remaining, silent members of the family are marked by histones carrying 
H3K9me3. As expected, the silent genes are bound by HP1 and incorporated into 
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heterochromatin that is segregated into the nuclear periphery, where they group 
together into 5-7 clusters (Freitas-Junior et al. 2000). Interestingly, the active 
member of the family is also found at the nuclear periphery, but it is separated from 
the silent genes into a subnuclear position that also includes the histone 
methyltransferase PfSET10 (Duraisingh et al. 2005; Ralph et al. 2005; Volz et al. 
2012). It is postulated that this methyltransferase is responsible for the H3K4me3 
modification found at the active var gene (Volz et al. 2012). An additional histone 
mark that appears to be important for var gene regulation is H3K36me3, a 
modification incorporated by the methyltransferase PfSET2 (Cui et al. 2008a) that 
in model eukaryotes is typically associated with transcriptional elongation. 
Surprisingly, disruption of the gene encoding PfSET2 completely disrupts mutually 
exclusive expression, leading to simultaneous expression of all members of the 
family and suggesting that H3K36me3 might be required for var gene silencing 
(Jiang et al. 2013). However, H3K36me3 is found within the body of both active 
and silent var genes, suggesting an alternative model in which this histone mark is 
required for recognition of var genes as members of the var gene family. This 
hypothesis has implications for coordination of gene expression and mutually 
exclusive expression.  
In addition to specific histone modifications associated with active and silent 
var genes, incorporation of variant histones into the nucleosomes found at specific 
regions of the genome also appears to contribute to var gene regulation. The 
variant histone H2A.Z is found within nucleosomes throughout the genome 
wherever H3K9ac and H3K4me3 are found (Bartfai et al. 2010; Petter et al. 2011), 
consistent with a role in maintaining euchromatin. While at most genes 
incorporation of H2A.Z is stable throughout the asexual cycle, at the single active 
var gene H2A.Z incorporation into nucleosomes at the promoter appears to be 
temporally regulated and is only observed at the point in the cycle when the var 
gene is actively transcribed (Petter et al. 2011), thus nucleosome exchange could 
play a role in var gene activation. In contrast, silent var genes are devoid of this 
histone variant. More recent work has identified double-variant histones that 
incorporate both H2A.Z and H2B.Z at transcriptionally active genomic regions, 
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including the active var gene promoter (Petter et al. 2013; Hoeijmakers et al. 
2013). The amount of double-variant histones found within intergenic regions 
correlates with the strength of the nearby promoters as well as the base 
composition of the underlying DNA, suggesting a model in which double-variant 
histones help to demarcate transcriptionally active and silent regions of the 
genome. 
 While the histone marks associated with active or silent var genes have now 
been identified, it is not yet clear how the histone modifiers are selectively targeted 
to specific genes to properly mark them for activation or silencing. DNA regulatory 
elements have been identified both within individual var genes (Brancucci et al. 
2012; Avraham et al. 2012) and separating genes within var tandem arrays (Wei et 
al. 2015), but their possible role in recruiting epigenetic factors remains 
uncharacterized. ncRNAs have been implicated in this process in many model 
eukaryotic systems, and similar mechanisms are likely to be at play with var genes. 
ncRNAs were first identified associated with var genes when this gene family was 
initially discovered, although their function was not understood (Su et al. 1995). 
These RNAs are transcribed from an RNA pol II promoter found within the 
conserved intron located within all var genes (Kyes et al. 2007). The intron is 
required for recognition of var genes for mutually exclusive expression (Deitsch et 
al. 2001; Dzikowski et al. 2007), and it has been shown to transcribe an antisense 
ncRNA from the single active gene while producing sense ncRNAs from all 
members of the family (Jiang et al. 2013; Amit-Avraham et al. 2015). The role of 
the ncRNAs themselves is not known, however targeting the antisense transcripts 
for degradation or over-expression greatly alters var gene expression patterns 
(Amit-Avraham et al. 2015), and an RNA exosome was recently identified that 
appears to be important for controlling antisense ncRNA levels (Zhang et al. 2014). 
Disruption of the RNAse activity of this exosome strongly affects var gene 
expression patterns. In addition to the ncRNAs themselves, the RNA pol II complex 
that transcribes them might also play a direct role in recruiting histone modifiers to 
var loci. PfSET2, the histone methyltransferase that deposits the H3K36me3 mark 
at var genes, binds to the C-terminal domain of RNA pol II and thus could be 
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recruited by the polymerase while it is transcribing the sense ncRNAs (Ukaegbu et 
al. 2014). This would explain why both active and silent genes are marked by 
H3K36me3, and is consistent with the hypothesis that this mark is responsible for 
genes to be recognized as members of the var gene family. Additional work will 
begin to decipher how these different aspects of var gene regulation integrate into 
an overall mechanism of control, and further how mutually exclusive expression 
and switching are coordinated. Work in the field will also help to determine how var 
gene switching integrates with selection by the human immune system (Abdi et al. 
2016), a topic that has not been extensively studied, and also how transmission 
through the mosquito potentially “resets” the expression patterns of clonally variant 
gene families (Spence et al. 2015). 
 
IMPORTANCE OF RESEARCH ON MALARIA EPIGENETICS IN THE CONTEXT 
OF ERADICATION 
 
 The new paradigm in the fight against malaria is eradication. An agenda has 
been developed to guide the steps that need to be undertaken to achieve this 
ambitious aim (Alonso et al. 2011). Considering the low expectations of having a 
highly effective vaccine available in the next few years, elimination efforts will have 
to rely mainly on vector control strategies and antimalarial drugs that could be used 
in mass drug administration schemes. Monitoring and diagnostic tools will also play 
important roles in elimination campaigns. Research on malaria epigenetics can 
contribute to the development of new public health tools that could facilitate 
elimination. 
  
Monitoring malaria phenotypes: genes under epigenetic regulation as 
markers for virulence and transmission potential 
 Malaria elimination campaigns will represent an extremely strong selective 
pressure for malaria parasites, which makes it reasonable to fear that such 
interventions may result in accelerated parasite evolution. There is a risk that 
elimination efforts may select for “super-parasites” with undesirable traits such as 
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increased virulence, more efficient transmission, increased resilience in front of low 
vector availability, increased resistance to multiple drugs, or even an increased 
ability to generate resistance to new drugs reminiscent of the accelerated 
resistance to multiple drugs (ARMD) phenotype (Rathod et al. 1997). Monitoring 
how parasite traits evolve during elimination campaigns is essential to avoid 
potentially disastrous consequences of the attempts to eradicate the disease. 
Monitoring will be necessary at the epidemiological level, but also at the genetic, 
phenotypic and epigenetic levels. Strong pressures can obviously result in the 
selection of genetic variants that confer increased fitness in front of the new 
challenges, but it is also possible that there is selection of parasites with epigenetic 
patterns that have an analogous effect. As described above, some parasite traits 
are associated with the expression of specific clonally variant genes: for example, 
expression of some var genes is associated with increased risk of severe disease 
(Jensen et al. 2004; Rottmann et al. 2006; Avril et al. 2012; Claessens et al. 2012; 
Lavstsen et al. 2012), and pfap2-g expression levels could be used as a proxy for 
parasite investment into sexual conversion and transmission. Expression of these 
genes and several others should be characterized in parasites that persist in 
settings where elimination efforts are not completely successful and a residual 
parasite population survives, albeit with altered epidemiology. This could help to 
understand the adaptive pathways of surviving parasites, as well as to appreciate 
the potential risks associated with the evolved parasites (e.g. increased virulence), 
or to identify their Achilles’ heels. 
 
Epigenetic regulation of gene expression as a target for therapeutic 
intervention: “epidrugs” 
 It is unclear whether existing drugs, used wisely, are sufficient to achieve 
success in malaria elimination campaigns. In any case, new antimalarial drugs with 
desirable properties such as being effective against all parasite stages or requiring 
a single dose, if available, would certainly facilitate the task. In this regard, 
epigenetic regulators are considered a promising new class of drug targets, with 
some attractive characteristics described below.  
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 Epigenetic regulation of gene expression is a highly dynamic process, 
implying that it is possible to alter normal epigenetic states through modulation of 
the enzymes involved in the process. Interfering pharmacologically with the 
delicate balance between the alternative epigenetic states of clonally variant genes 
could compromise parasite survival in several ways (Fig. 3). First, inhibiting the 
epigenetic factors that are necessary for var silencing could result in parasites that 
simultaneously express multiple forms of PfEMP1, inducing the development of 
broadly reactive immune responses that eliminate the current infection and 
additionally confer protection against future infections. An analogous strategy to 
disrupt normal antigenic variation has been successfully applied to induce 
protective immunity against Giardia lambia in rodent models of disease (Rivero et 
al. 2010). Second, altering the balance between the active and silenced states of 
pfap2-g could result in either massive sexual conversion or no production of sexual 
forms, both with catastrophic consequences for the parasite. It is important to note 
that malaria elimination efforts would tremendously benefit from drugs that kill 
gametocytes and consequently prevent transmission, but gametocytes are highly 
resilient to chemical attack and most current antimalarial drugs are not efficient 
against them (malERA Consultative Group on Drugs 2011). Thus, inhibiting the 
epigenetic mechanisms that drive the conversion of parasites into sexual forms 
arguably provides an attractive alternative to directly targeting gametocytes. Third, 
inhibiting malaria chromatin modifiers that do not specifically regulate clonally 
variant genes but participate in normal cell cycle progression could directly kill the 
parasites.  
 Orthologs of many known chromatin modifiers have been identified in the P. 
falciparum genome (Cui et al. 2008a; Bischoff and Vaquero 2010). The first 
obvious targets for antimalarial “epidrug” development are the enzymes that add or 
remove acetyl or methyl groups from histone tails (Table 2). Importantly, inhibitors 
of this type of enzymes have been developed for the fight against other diseases 
such as cancer, providing a large number of chemical starting points and a wealth 
of knowledge that could be used for the development of malaria-specific epigenetic 
inhibitors (Arrowsmith et al. 2012). Several compounds that were identified as 
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inhibitors of histone deacetylases (HDACs) or acetyltransferases (HATs) in other 
eukaryotes inhibit P. falciparum growth, and some of them have a more potent 
effect on malaria parasites than on human cells (Merrick and Duraisingh 2007; Cui 
et al. 2008b; Andrews et al. 2012a; Andrews et al. 2012b; Duffy et al. 2014). 
Inhibitors of P. falciparum lysine methyl-transferases (KMTs) have also been 
identified and shown to effectively kill malaria parasites of different species and at 
different stages of development (Malmquist et al. 2012; Malmquist et al. 2015). 
Furthermore, a sublethal concentration of one such compound, chaetocin, was 
recently shown to alter the epigenetic regulation of var gene expression by 
increasing the frequency of expression switches in this gene family (Ukaegbu et al. 
2015). Interestingly, another KMT inhibitor was shown to activate dormant liver 
forms called hypnozoites (Dembele et al. 2014), which are produced by some 
malaria parasite species including P. vivax and are considered one of the less 
accessible malaria infection reservoirs. This observation raises the intriguing 
possibility that hypnozoite activation may be regulated at the epigenetic level. If this 
is the case, it may be possible to target these highly resilient forms with epigenetic 
drugs.   
 
FUTURE PERSPECTIVES 
 
 Epigenetics continues to be a vibrant field of investigation in all eukaryotic 
systems, from animals to plants to protozoans. Given their somewhat “stripped 
down” repertoire of transcription factors, it is likely to play an even bigger role in the 
biology of malaria parasites. With the development of drugs that target epigenetic 
factors as therapies for human diseases like autoimmune disorders or cancer, this 
rapidly evolving technology can be applied to the development of antimalarial 
compounds that kill parasites, reduce virulence and disrupt transmission, all key 
components of any elimination/eradication campaign. Along the way these 
compounds will also serve as tools for investigating the basic biology of these 
evolutionary distant and fascinating organisms. The recent development of new 
technologies for genetic manipulation of the parasites, including powerful methods 
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for genome editing, will also contribute to addressing some of the burning 
questions in the malaria epigenetics field described in this chapter. Considering 
that epigenetics often studies properties that vary from one cell to another, it will be 
important to also develop improved technologies for analysis at the single-cell 
level, which could bring enormous progress to the field. 
 
CONCLUDING REMARKS 
 
 It is exciting to once again consider the prospects of malaria elimination and 
eradication after such plans were previously abandoned decades ago. Recent 
gains in reducing the global malaria burden provide tantalizing hope that 
elimination is indeed possible. Nonetheless, for progress against the disease to be 
sustained, new intervention strategies will be required as drug and insecticide 
resistance inevitably arise. As funds and resources are devoted to disease 
reduction in the field, it will be important not to neglect basic research into the 
fundamental biology of the parasite and its mosquito vector. It is this discovery 
process that will yield the drugs, vaccines and intervention strategies of the future 
that will be required for the ultimate eradication of malaria. Epigenetics is one such 
field that is rapidly developing and likely to be a rich source of novel targets for 
antimalaria strategies.  
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Gene ID 
(previous ID) 
Protein name Proposed function Notes References 
PF3D7_1222600 
(PFL1085w) 
PfAP2-G Transcription factor implicated in 
sexual differentiation. 
Protein contains an AP2 DNA 
binding domain. 
(Kafsack et al. 2014) 
 
PF3D7_1036300 
(PF10_0355) 
 
MSPDBL2 
 
A likely merozoite surface protein, 
possibly involved in erythrocyte 
invasion. 
Gene under strong balancing 
selection. Possible role in drug 
resistance. 
(Amambua-Ngwa et al. 2012; 
Hodder et al. 2012; Van Tyne 
et al. 2013) 
PF3D7_1301600 
(MAL13P1.60) 
 
EBA140 Merozoite protein involved in 
erythrocyte invasion, binds to 
glycophorin C. 
Enables parasites to utilize 
alternative invasion pathways. 
(Maier et al. 2003; Cortés et 
al. 2007; Crowley et al. 2011) 
 
PF3D7_0424200 
(PFD1150c) 
 
PfRH4 Merozoite protein involved in 
erythrocyte invasion, binds to 
complement receptor 1 (CR1). 
Enables parasites to utilize 
alternative invasion pathways. 
(Stubbs et al. 2005; Jiang et 
al. 2010) 
 
var gene family 
(~60 members) 
PfEMP1 Cytoadhesive protein displayed on the 
surface of the infected erythrocyte. 
Displays mutually exclusive 
expression, changes in 
expression enable antigenic 
variation. 
(Chookajorn et al. 2007; 
Lopez-Rubio et al. 2007; Jiang 
et al. 2013) 
rif gene family 
(~160 members) 
RIFIN Displayed on the surface of the 
infected erythrocyte, some members 
of the family have been linked to 
rosetting. 
Most members of the family 
silent at any given time, 
expression has also been 
reported in merozoites. 
(Kyes et al. 1999; Fernandez 
et al. 1999; Mwakalinga et al. 
2012; Goel et al. 2015) 
stevor gene family 
(~31 members) 
STEVOR Displayed on the surface of the 
infected erythrocyte. Contribute to 
infected erythrocyte mechanical 
properties. 
Most members of the family 
silent at any given time, 
expression has also been 
reported in merozoites and 
gametocytes. 
(Lavazec et al. 2007; Sanyal 
et al. 2012; Niang et al. 2014) 
 
Pfmc-2tm gene 
family 
(~12 members) 
PFMC-2TM Displayed on the surface of the 
infected erythrocyte. 
Most members of the family 
silent at any given time. 
(Sam-Yellowe et al. 2004; 
Lavazec et al. 2007) 
 
surfin gene family 
(~10 members) 
SURFIN Unknown function. Several localizations reported 
including infected erythrocyte 
surface and merozoites. 
(Winter et al. 2005; Mphande 
et al. 2008) 
clag gene family 
(5 members) 
CLAG At least some members are implicated 
in formation of the PSAC channel 
found in the infected erythrocyte 
membrane. 
clag3.1 and clag3.2 are 
expressed in a mutually 
exclusive fashion, whereas 
clag2 shows independent 
clonally variant expression. 
(Cortés et al. 2007; Comeaux 
et al. 2011; Crowley et al. 
2011; Nguitragool et al. 2011) 
phist gene families 
(~79 members) 
PHIST-domain 
proteins 
Cytoadherence / erythrocyte 
remodeling. 
Various families of exported 
proteins; at least some PHIST-
domain proteins interact with 
PfEMP1 at knobs 
(Sargeant et al. 2006; 
Proellocks et al. 2014; Oberli 
et al. 2014) 
exported dnaj III 
gene family 
(~9 members) 
DnaJ III / 
HSP40 
Erythrocyte remodeling. Exported proteins with a J-
domain; HSP40-type 
chaperones. 
(Sargeant et al. 2006) 
hyp gene families 
(~55 members) 
HYP Unknown function. Various families of exported 
proteins. 
(Sargeant et al. 2006) 
fikk gene family 
(~23 members) 
FIKK Erythrocyte remodeling. Exported kinases. (Sargeant et al. 2006; Nunes 
et al. 2007; Kats et al. 2014) 
gbp gene family 
(3 members) 
Glycophorin 
binding protein 
(GBP) 
Unknown. Exported proteins. (Sargeant et al. 2006) 
 
acs gene family 
(~13 members) 
Acyl-CoA 
synthetase 
(ACS) 
Lipid metabolism (synthesis and/or 
transport). 
Gene family specifically 
amplified in P. falciparum. 
(Bethke et al. 2006) 
acbp gene family 
(4 members) 
Acyl-coA 
binding protein 
(ACBP) 
Lipid metabolism (synthesis and/or 
transport). 
Not characterized. (Bethke et al. 2006) 
Table 1. Examples of genes or gene families that display clonally variant 
expression linked to the histone modification H3K9me3 (when transcriptionally 
silent) in P. falciparum. Inclusion of a gene or gene family in this table is based on 
direct observation of clonally variant expression (Rovira-Graells et al. 2012) and 
presence of epigenetic marks of silencing (Lopez-Rubio et al. 2009; Flueck et al. 
2009) in genome-wide studies, or in the specific references provided. Both current 
3D7 ID numbers and previous ID numbers are provided, along with a brief, general 
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description of the predicted function. The estimates of the number of genes in each 
family do not include pseudogenes. 
 
Protein name Gene ID  
(previous ID) 
Proposed function References 
Histone methyltransferases   
PfSET1 
 
PF3D7_0629700 
(PFF1440w) 
Involved in the deposition of the epigenetic mark 
H3K4me3. 
(Cui et al. 2008a) 
PfSET2 (also 
called PfSETvs) 
PF3D7_1322100 
(MAL13P1.122) 
 
Involved in the deposition of the epigenetic mark 
H3K36me2/3, participates in var regulation. 
(Cui et al. 2008a; Kishore et al. 
2013; Jiang et al. 2013; Ukaegbu 
et al. 2014) 
PfSET3 (also 
called PfKMT1) 
PF3D7_0827800 
(PF08_0012) 
Involved in the deposition of the epigenetic mark 
H3K9me2/3. 
(Cui et al. 2008a; Lopez-Rubio et 
al. 2009; Volz et al. 2010) 
PfSET4 
 
PF3D7_0910000 
(PFI0485c) 
Involved in the deposition of epigenetic marks on 
H3K4. 
(Cui et al. 2008a; Volz et al. 2010; 
Jiang et al. 2013) 
PfSET5 
 
PF3D7_1214200 
(PFL0690c) 
Involved in the deposition of unknown epigenetic 
marks. Mitochondrial localization also reported. 
(Cui et al. 2008a; Volz et al. 2010; 
Jiang et al. 2013) 
PfSET6 
 
PF3D7_1355300 
(PF13_0293) 
Involved in the deposition of epigenetic marks on 
H3K4. 
(Cui et al. 2008a; Volz et al. 2010) 
PfSET7 
 
PF3D7_1115200 
(PF11_0160) 
In vitro data suggest methylation of H3K4 and 
H3K9. 
(Cui et al. 2008a) 
(Chen et al. 2016) 
PfSET8 
 
PF3D7_0403900 
(PFD0190w) 
Involved in the deposition of the epigenetic mark 
H4K20me1/2/3. 
(Cui et al. 2008a; Kishore et al. 
2013; Jiang et al. 2013) 
PfSET9 
 
PF3D7_0508100 
(PFE0400w) 
Involved in the deposition of unknown epigenetic 
marks. 
(Cui et al. 2008a) 
PfSET10 PF3D7_1221000 
(PFL1010c) 
Involved in the deposition of the epigenetic mark 
H3K4me3, localized to the var expression site. 
(Volz et al. 2012) 
Histone demethylases   
JmjC1 PF3D7_0809900 
(MAL8P1.111) 
Involved in the removal of epigenetic marks from 
H3K9 and H3K36. 
(Cui et al. 2008a; Jiang et al. 
2013) 
JmjC2 PF3D7_0602800 
(PFF0135w) 
Involved in the removal of unknown epigenetic 
marks.  
(Cui et al. 2008a; Jiang et al. 
2013) 
LSD1 PF3D7_1211600 
(PFL0575w) 
Involved in the removal of unknown epigenetic 
marks. 
(Iyer et al. 2008; Volz et al. 2010; 
Jiang et al. 2013)  
Histone acetyltransferases   
PfGCN5 PF3D7_0823300 
(PF08_0034) 
Involved in the deposition of the epigenetic 
marks H3K9ac and H3K14ac. 
(Fan et al. 2004; Cui et al. 2007) 
PfHAT1 PF3D7_0416400 
(PFD0795w) 
Probable ortholog to HAT1 in higher eukaryotes.  
PfMYST PF3D7_1118600 
(PF11_0192) 
Member of the MYST family of 
acetyltransferases, proposed to acetylate H4K5, 
K8, K12 and K16. 
(Miao et al. 2010) 
Histone deacetylases   
PfSIR2A  
PfSIR2B 
PF3D7_1328800 
(PF13_0152) 
PF3D7_1451400 
(PF14_0489) 
Involved in telomere maintenance and regulation 
of var gene expression. 
(Duraisingh et al. 2005; Freitas-
Junior et al. 2005; Tonkin et al. 
2009; Merrick et al. 2015) 
PfHDAC1 PF3D7_0925700 
(PFI1260c) 
Putative class I histone deacetylase, probable 
ortholog of Rpd3 from yeast. 
(Joshi et al. 1999; Andrews et al. 
2012b) 
PfHDAC2 PF3D7_1472200 
(PF14_0690) 
Putative class II histone deacetylase. (Andrews et al. 2012b) 
PfHDAC3 (also 
called PfHda2) 
PF3D7_1008000 
(PF10_0078) 
Putative class II histone deacetylase, linked to 
var gene silencing and sexual differentiation  
(Andrews et al. 2012b; Coleman 
et al. 2014) 
Other    
PfBDP1 PF3D7_1033700 
(PF10_0328) 
Bromodomain protein 1, involved in the 
regulation of genes linked to erythrocyte 
invasion. 
(Josling et al. 2015) 
PfHP1 PF3D7_1220900 
(PFL1005c) 
Heterochromatin protein 1, involved in 
maintenance of silenced regions of the genome, 
linked to var gene silencing and sexual 
differentiation 
(Perez-Toledo et al. 2009; Flueck 
et al. 2009; Brancucci et al. 2014) 
Table 2. List of putative epigenetic factors involved in controlling chromatin 
structure and epigenetic regulation in P. falciparum. Both current 3D7 ID numbers 
and previous numbers are provided, along with a brief, general description of the 
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predicted function. Many of the listed functions are predicted based on 
computational analysis and have not been experimentally verified. Several 
additional uncharacterized putative epigenetic factors have been predicted by in 
silico analysis (Bischoff and Vaquero 2010). 
 
FIGURE LEGENDS 
 
Figure 1. Clonally variant gene expression during the blood stages of the P. 
falciparum life cycle. Asexual replication occurs within human erythrocytes and 
progresses through different morphological stages including rings, trophozoites, 
schizonts and merozoites (cycle at top of figure). In trophozoites, several clonally 
variant proteins involved in erythrocyte modification, antigenic variation and cell 
permeability are expressed. Similarly, in schizonts/merozoites clonally variant 
proteins that determine alternative erythrocyte invasion pathways are expressed. In 
a small proportion of cells, the sexual differentiation process is initiated through the 
activation of PfAP2-G, leading to the production of male and female gametocytes 
(bottom).  
 
Figure 2. Chromatin compartments in P. falciparum. As in other eukaryotes, the 
chromatin of malaria parasites can be roughly divided into three separate 
compartments with very distinct properties. Green and red flags represent histone 
marks generally associated with transcriptional activation or silencing, respectively. 
P. falciparum constitutive heterochromatin (upper left) is generally transcriptionally 
silent but allows transcription of some ncRNAs. Euchromatic regions (upper right) 
are typified by the incorporation of the variant histones H2A.Z and H2B.Z as well 
as the histone modifications H3K4me3 and H3K9ac. Stage-specific transcription 
largely depends on the presence of specific transcription factor(s) (TF), whereas in 
facultative heterochromatin (bottom) transcription depends on both presence of the 
relevant transcription factor(s) and chromatin accessibility. The latter is determined 
by which of the possible chromatin states has been assembled at a specific locus 
in a given cell. Typically, chromatin at silent loci incorporates the histone 
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modification H3K9me3 and is bound by HP1 whereas active genes are associated 
with the histone modification H3K9ac. 
 
Figure 3. Epigenetic factors as targets for drug development. The normal 
balance between the euchromatic (active) and heterochromatic (silenced) states of 
clonally variant genes (top panel) can be altered pharmacologically. Drugs that 
inhibit the factors that catalyze the transition to or the maintenance of the active 
state are expected to shift the balance towards the silenced state (middle panel). In 
contrast, drugs that inhibit the factors that catalyze the transition to or the 
maintenance of the silenced state are expected to shift the balance towards the 
active state (bottom panel). The predicted effects of chemical inhibition of enzymes 
that participate in the regulation of clonally variant genes in general are listed. As 
examples, enzymes that operate on H3K9 are shown, but inhibition of enzymes 
that regulate the deposition or removal of other histone modifications (e.g. 
H4K20me3) may have similar effects. Inhibitors of epigenetic factors that 
participate in the regulation of only some clonally variant gene families (e.g. var 
genes) are expected to have family-specific effects. The predicted histone 
acetyltransferases (HATs), lysine demethylases (KDMs), histone deacetylases 
(HDACs) and lysine methyltransferases (KMTs) that operate on H3K9 are 
described in Table 2. 
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